Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study
Abstract
We evaluated a new antiviral agent, ribavirin, in the treatment of infants hospitalized with lower-respiratory-tract disease from respiratory syncytial virus. Ribavirin or placebo was administered to 33 infants in a double-blind manner by continuous aerosol for three to six days. Seventeen infants w …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
clinical trials as topic
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
u.s. gov't
female
male
Child
Infant
newborn
P.H.S.
preschool
Clinical Trial
Randomized Controlled Trial
Double-Blind Method
Random Allocation
respiratory syncytial viruses / isolation & purification
c b hall
aerosols
respiratory tract infections / drug therapy*
respirovirus infections / drug therapy*
ribavirin / administration & dosage*
antiviral agents / administration & dosage*
j t mcbride
ribonucleosides / administration & dosage*
pmid:6343860
doi:10.1056/nejm198306163082403
w j hall
Access
Citation
ID:
121287
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
121287
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet
